Inception Return
(9/27/1993)
|
2.36 %
|
|
YTD Return
|
-10.81 %
|
|
NAVPS
(12/14/2018)
|
$14.96
|
|
Change
|
($0.22) / -1.44 %
|
|
|
Growth of $10,000
(As of November 30, 2018)
|
|
MER
|
2.75 %
|
|
Assets ($mil)
|
$132.33
|
|
Rank (1Yr)
|
30/30
|
|
Std Dev (3Yr)
|
14.57 %
|
|
Volatility Ranking (3Yr)
|
10/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The fund aims to provide long-term growth through capital appreciation by investing primarily in equity securities or securities convertible to equity securities of companies in Asia, the Pacific Rim, Australasia, and the Indian subcontinent. We will not change the fundamental investment objectives of the Fund without the consent of unitholders by a majority of votes cast at a meeting of unitholders.
|
Management Co.
CIBC Asset Management Inc.
Managers
CIBC Global Asset Management Team, Mark Lin
|
|
Asset Allocation
(As of November 30, 2018)
|
Sector Allocation
(As of November 30, 2018)
|
Geographic Allocation
(As of November 30, 2018)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Cochlear Ltd | International Equity | Healthcare | Asia/Pacific Rim | 3.80% |
| Daikin Industries Ltd | International Equity | Industrial Goods | Japan | 3.72% |
| Ryman Healthcare Ltd | International Equity | Healthcare | Asia/Pacific Rim | 3.70% |
| Alibaba Group Holding Ltd - ADR | International Equity | Technology | Asia/Pacific Rim | 3.49% |
| Fisher & Paykel Healthcare Corp Ltd | International Equity | Healthcare | Asia/Pacific Rim | 3.47% |
| Terumo Corp | International Equity | Healthcare | Japan | 3.37% |
| Tencent Holdings Ltd | International Equity | Telecommunications | Asia/Pacific Rim | 3.24% |
| Sonic Healthcare Ltd | International Equity | Healthcare | Asia/Pacific Rim | 3.22% |
| Australia New Zealand Banking Group Ltd | International Equity | Financial Services | Asia/Pacific Rim | 3.17% |
| Keyence Corp | International Equity | Industrial Goods | Japan | 2.94% |
Performance Data
(As of November 30, 2018)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
3.74
|
-9.33
|
-13.62
|
-10.81
|
-13.16
|
4.60
|
8.52
|
8.46
|
|
Benchmark
|
4.55
|
-4.95
|
-7.37
|
-4.21
|
-4.75
|
7.48
|
9.22
|
9.85
|
|
Quartile Ranking
|
3
|
4
|
4
|
4
|
4
|
2
|
1
|
1
|
|
Calendar Return (%)
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
2010
|
2009
|
2008
|
|
Fund
|
31.91
|
-7.71
|
27.03
|
7.68
|
19.15
|
13.30
|
-17.36
|
4.99
|
18.77
|
-26.33
|
|
Benchmark
|
22.81
|
1.58
|
18.45
|
9.76
|
20.81
|
13.22
|
-13.46
|
11.84
|
16.35
|
-25.85
|
|
Quartile Ranking
|
1
|
4
|
1
|
2
|
1
|
2
|
2
|
4
|
1
|
3
|
MSCI ESG Fund Metrics (As of December 01, 2018)
|
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.